Cargando…

The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences

BACKGROUND: In 2014 the European Medicines Agency included exon 2, 3 and 4 KRAS and NRAS testing for the selection of metastatic colorectal cancer (mCRC) patients eligible for the therapy with anti-EGFR monoclonal antibodies. The Italian Association of Medical Oncology (AIOM) and the Italian Society...

Descripción completa

Detalles Bibliográficos
Autores principales:	Normanno, Nicola, Pinto, Carmine, Castiglione, Francesca, Fenizia, Francesca, Barberis, Massimo, Marchetti, Antonio, Fontanini, Gabriella, De Rosa, Gaetano, Taddei, Gian Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557483/ https://www.ncbi.nlm.nih.gov/pubmed/26335936 http://dx.doi.org/10.1186/s12967-015-0655-1

Ejemplares similares

External quality assessment for EGFR mutations in Italy: improvements in performances over the time
por: Normanno, Nicola, et al.
Publicado: (2017)

KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment
por: Normanno, Nicola, et al.
Publicado: (2011)

The ideal reporting of RAS testing in colorectal adenocarcinoma: a pathologists’ perspective
por: Malapelle, Umberto, et al.
Publicado: (2023)

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)
por: Normanno, Nicola, et al.
Publicado: (2020)

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer
por: Fairley, Jennifer A., et al.
Publicado: (2022)

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories
por: Capoluongo, Ettore, et al.
Publicado: (2019)

KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting
por: Barone, Carlo, et al.
Publicado: (2014)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
por: Keppens, Cleo, et al.
Publicado: (2018)

Stillbirths at Term: Case Control Study of Risk Factors, Growth Status and Placental Histology
por: Mecacci, Federico, et al.
Publicado: (2016)

Correction: Stillbirths at Term: Case Control Study of Risk Factors, Growth Status and Placental Histology
por: Mecacci, Federico, et al.
Publicado: (2019)

RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells
por: De Luca, Antonella, et al.
Publicado: (2014)

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC-03-2018)
por: Damato, Angela, et al.
Publicado: (2020)

Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network
por: Marchetti, Antonio, et al.
Publicado: (2021)

Estimation of inter-laboratory reference change values from external quality assessment data
por: Paal, Michael, et al.
Publicado: (2021)

Challenges in bioinformatics approaches to tumor mutation burden analysis
por: Fenizia, Francesca, et al.
Publicado: (2021)

Italian inter-society expert panel position on radiological exposure in Neonatal Intensive Care Units
por: del Vecchio, Antonella, et al.
Publicado: (2020)

Maintenance of Wakefulness and Occupational Injuries among Workers of an Italian Teaching Hospital
por: Valent, Francesca, et al.
Publicado: (2016)

Organization and Activity of Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging
por: Ciampi, Quirino, et al.
Publicado: (2023)

Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group
por: Zannoni, Gian Franco, et al.
Publicado: (2022)

In vitro diagnostic company recalls and medical laboratory practices: an Italian case
por: Lima-Oliveira, Gabriel, et al.
Publicado: (2015)

Opening of inter-Laboratory link
Publicado: (1973)

“The Italian Study on Recovery 2” Phase 1: Psychometric Properties of the Recovery Assessment Scale (RAS), Italian Validation of the Recovery Assessment Scale
por: Boggian, Ileana, et al.
Publicado: (2020)

High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer
por: Jeantet, Marion, et al.
Publicado: (2016)

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients
por: Rachiglio, Anna Maria, et al.
Publicado: (2019)

An inter-laboratory trial as a tool to increase rabies diagnostic capabilities of Sub-Saharan African Veterinary laboratories
por: Gourlaouen, Morgane, et al.
Publicado: (2020)

RAS testing in metastatic colorectal cancer: advances in Europe
por: Van Krieken, J Han JM, et al.
Publicado: (2015)

Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements
por: Natali, Patrizia, et al.
Publicado: (2022)

Italian cinema today : 1952 - 1965
por: Rondi, Gian Luigi
Publicado: (1966)

Provision of follow-up care for women with a history of breast cancer following the 2016 position paper by the Italian Group for Mammographic Screening and the Italian College of Breast Radiologists by SIRM: a survey of Senonetwork Italian breast centres
por: Deandrea, Silvia, et al.
Publicado: (2022)

Inter-laboratory Synchronization for the CNGS Project
por: Serrano, Javier, et al.
Publicado: (2006)

Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy
por: Ciardiello, Davide, et al.
Publicado: (2021)

Ras Oncogene-Mediated Progressive Silencing of Extracellular Superoxide Dismutase in Tumorigenesis
por: Cammarota, Francesca, et al.
Publicado: (2015)

Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel
por: Malapelle, Umberto, et al.
Publicado: (2020)

Biomarker testing in oncology – Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL
por: Dufraing, K., et al.
Publicado: (2020)

Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors
por: Mauro, Concetta Di, et al.
Publicado: (2017)

Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies
por: Rachiglio, Anna Maria, et al.
Publicado: (2022)

FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial
por: Damato, Angela, et al.
Publicado: (2021)

Inter-laboratory and inter-operator reproducibility in gait analysis measurements in pediatric subjects
por: Scalona, Emilia, et al.
Publicado: (2019)

Autoantibody Diagnostics in Neuroimmunology: Experience From the 2018 Italian Neuroimmunology Association External Quality Assessment Program
por: Gastaldi, Matteo, et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension
por: Mancusi, Costantino, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ou3fapfaotnhk0incan83iij9o